Fate Therapeutics, Inc. · NASDAQ:FATE
BlackRock, Inc. reported a 6.90% stake in Fate Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 23, 2025
BlackRock, Inc. reported a 6.90% stake in Fate Therapeutics, Inc., 7,852,183 shares, as a passive investor on Mar 31, 2025. Filed Apr 23, 2025 (Schedule 13G/A).
- Stake
- 6.90%
- Shares
- 7,852,183
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.90% | 7,852,183 |